Development and Polit Study of Get Ready With my Heart Program

Launched by CHILDREN'S HOSPITAL OF FUDAN UNIVERSITY · May 13, 2024

Keywords

ClinConnect Summary

This clinical trial, called the "Get Ready With my Heart Program," is designed to help young people with congenital heart disease (CHD) transition from pediatric to adult healthcare. The main goal is to see if this program can improve how well these young adults are prepared for this important change in their medical care. Researchers want to find out if the program is easy to use and if it actually helps participants feel more ready to manage their own health.

To join the trial, participants should be between 12 and 21 years old and have been diagnosed with congenital heart disease for at least six months. They need to be receiving regular check-ups at Fudan University Children's Hospital and be able to understand the program’s materials. Those who are selected will either take part in the Get Ready with my Heart Program or receive standard care, and researchers will check how well they adjust to the transition at three and six months after starting the program. This study is currently looking for new participants, so if you think you or someone you know might qualify, it could be a great opportunity to gain support during this transition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age between 12 and 21 years;
• • 2. Diagnosed with congenital structural heart disease for at least 6 months;
• • 3. Regularly receiving outpatient follow-up at Fudan University Children's Hospital;
• • 4. Cognitive abilities corresponding to age, with adequate reading and comprehension skills;
• • 5. Informed consent provided.
• Exclusion Criteria:
• • 1. Patients with physical conditions that limit participation (e.g., severe heart failure);
• • 2. Presence of other congenital malformations (e.g., various syndromes caused by chromosomal abnormalities);
• • 3. Patients with psychiatric disorders such as schizophrenia, intellectual disabilities, visual impairments, or other conditions that preclude participation in the study.